| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.35 | 3e-07 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.26 | 4e-05 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.19 | 5e-05 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.24 | 0.001 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.002 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.21 | 0.002 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.003 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.004 |